Clinical trial
Drug Treatment for Pathologic Gambling Disorder
NCT00053677 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00053677 |
|---|---|
| Title | Drug Treatment for Pathologic Gambling Disorder |
| Official title | Naltrexone Treatment in Pathologic Gambling Disorder |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gambling |
| Intervention type | Drug |
| Interventions | Naltrexone, Placebo |
| Enrollment | 83 |
| Start date | Dec 1, 2002 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Feb 5, 2003 |
| Last update posted | Feb 23, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: